Table 5. Comparative analysis of altered transcript expression in FTC, PTC* and PDTC samples.
Gene | all FTC | oncocytic FTC with vascular invasion | all PTC* | more aggressive* PTC | all PDTC | oncocytic PDTC |
---|---|---|---|---|---|---|
BCL2 | −1.48 | −2.01 | −3.17 | −3.24 | −2.63 | −5.37 |
CHEK1 | 9.06 | 13.40 | 2.97 | 3.01 | 25.14 | 33.02 |
CRY2 | −1.32 | −1.71 | −1.92 | −2.02 | −2.07 | −3.38 |
c-KIT | −5.06 | −10.13 | −10.80 | −12.21 | −9.98 | −43.36 |
DIO2 | −1.61 | −1.76 | −3.61 | −3.65 | −3.10 | −4.87 |
FZD1 | −1.17 | −2.23 | NA | NA | −2.68 | −5.53 |
KDR | −1.48 | −1.73 | NA | NA | −3.68 | −5.90 |
PER2 | −1.62 | −2.90 | −1.55 | −1.63 | −3.06 | −6.46 |
SLC26A4 | −2.19 | −3.87 | NS | NS | −17.79 | −36.62 |
TG | −2.43 | −5.42 | −3.85 | −4.23 | −10.60 | −37.29 |
TPO | −3.52 | −5.42 | −28.31** | −23.22** | −28.68 | −62.72 |
NS - non significant.
NA - not assessed.
Based on the results previously published by us [8].
Highly variable expression.